Your browser doesn't support javascript.
loading
Overcoming mutation-based resistance to antiandrogens with rational drug design.
Balbas, Minna D; Evans, Michael J; Hosfield, David J; Wongvipat, John; Arora, Vivek K; Watson, Philip A; Chen, Yu; Greene, Geoffrey L; Shen, Yang; Sawyers, Charles L.
Affiliation
  • Balbas MD; Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences , Memorial Sloan-Kettering Cancer Center , New York , United States ; Human Oncology and Pathogenesis Program , Memorial Sloan-Kettering Cancer Center , New York , United States.
Elife ; 2: e00499, 2013 Apr 09.
Article in En | MEDLINE | ID: mdl-23580326
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Androgen Antagonists / Mutation Limits: Humans / Male Language: En Journal: Elife Year: 2013 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Androgen Antagonists / Mutation Limits: Humans / Male Language: En Journal: Elife Year: 2013 Document type: Article Affiliation country: Estados Unidos